KCM
AGTC

Kingdon Capital Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Kingdon Capital Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,225,000
Closed -$333K – 81
2022
Q3 		$333K Buy
+1,225,000
New +$535K 0.04% 58

Kingdon Capital Management's AGTC Position: Q4 2022 in Review

Kingdon Capital Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 1,225,000 shares — an estimated $333K sold.

Kingdon Capital Management first reported a position in AGTC in Q3 2022 and held it in 1 quarter. The position peaked at $333K in Q3 2022. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.

  • Kingdon Capital Management reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
  • Kingdon Capital Management sold 1,225,000 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $333K.
  • Kingdon Capital Management first reported a position in Applied Genetic Technologies Corporation in Q3 2022 and held it in 1 quarter.
  • Kingdon Capital Management's Applied Genetic Technologies Corporation position peaked at $333K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.

Based on Kingdon Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.